… SSc renal crisis, SSc-associated pulmonary arterial hypertension (SSc-PAH) has emerged
… represents a significant proportion of the pulmonary arterial hypertension (PAH) population (…

… Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of
death in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …

… Pulmonary arterial hypertension (PAH) is an important cause of mortality in systemic sclerosis
(SSc). The symptoms are non-specific and can be ascribed to other features of the disease…

… Survival in incident systemic sclerosis patients with pulmonary arterial hypertension (PAH).
Overall survival was 90% (95% CI 81% to 95%), 78% (95% CI 67% to 86%) and 56% (95% …

… systemic sclerosis–related pulmonary arterial hypertension (SSc-PAH) and idiopathic pulmonary
arterial hypertension (… antagonists; mPAP = mean pulmonary arterial pressure; NYHA = …

… Screening allows for early management of pulmonary arterial hypertension (PAH), a severe
complication of systemic sclerosis (SSc). Since no consensus has been reached on the …

… compared with idiopathic pulmonary arterial hypertension (IPAH)… systemic sclerosis–related
pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular …

… pulmonary hypertension and were referred for endarterectomy and 19 had post-capillary
pulmonary hypertension (… institution for investigation for pulmonary arterial hypertension. All 72 …

… Comparison of screening algorithms for pulmonary arterial hypertension (PAH) in systemic
sclerosis. a) The DETECT algorithm and b) the Australian Scleroderma Interest Group (ASIG) …

… whether the survival of patients with pulmonary hypertension related to systemic sclerosis
(SScPH) was different from that of patients with other forms of pulmonary arterial hypertension. …